$MASS
908 Devices Inc.

2022 Q3 Form 10-Q Financial Statement

#000155837022012746 Filed on August 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $15.80M $11.11M $8.306M
YoY Change 25.92% 34.18% 49.85%
Cost Of Revenue $6.459M $4.472M $4.177M
YoY Change 12.66% 14.73% 58.52%
Gross Profit $9.338M $6.634M $4.129M
YoY Change 37.08% 51.5% 41.99%
Gross Profit Margin 59.11% 59.73% 49.71%
Selling, General & Admin $11.83M $10.71M $9.745M
YoY Change 34.6% 22.0% 69.39%
% of Gross Profit 126.64% 161.44% 236.01%
Research & Development $4.666M $4.293M $3.905M
YoY Change 41.31% 40.52% 31.7%
% of Gross Profit 49.97% 64.71% 94.57%
Depreciation & Amortization $459.0K $311.0K $267.0K
YoY Change 75.86% 32.34% 94.89%
% of Gross Profit 4.92% 4.69% 6.47%
Operating Expenses $16.49M $15.00M $13.65M
YoY Change 36.43% 26.78% 56.57%
Operating Profit -$7.154M -$8.369M -$9.521M
YoY Change 35.6% 12.26% 63.87%
Interest Expense $33.00K $15.00K $20.00K
YoY Change 6.45% -61.54% -94.68%
% of Operating Profit
Other Income/Expense, Net $895.0K $270.0K $106.0K
YoY Change 883.52% 770.97% -137.19%
Pretax Income -$6.259M -$8.099M -$9.415M
YoY Change 20.71% 9.09% 54.34%
Income Tax
% Of Pretax Income
Net Earnings -$6.259M -$8.099M -$9.415M
YoY Change 20.71% 9.09% 54.47%
Net Earnings / Revenue -39.62% -72.92% -113.35%
Basic Earnings Per Share -$0.20 -$0.26 -$0.30
Diluted Earnings Per Share -$0.20 -$0.26 -$0.30
COMMON SHARES
Basic Shares Outstanding 31.59M 31.41M 31.21M
Diluted Shares Outstanding 31.61M 31.41M 31.21M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.7M $213.0M $223.1M
YoY Change 39.54% 50.72% 49.74%
Cash & Equivalents $193.7M $213.0M $223.1M
Short-Term Investments
Other Short-Term Assets $3.222M $3.408M $3.908M
YoY Change 60.94% 39.61% 39.57%
Inventory $11.73M $11.18M $9.632M
Prepaid Expenses
Receivables $15.23M $11.10M $6.323M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $223.9M $238.7M $243.0M
YoY Change 42.16% 51.84% 49.11%
LONG-TERM ASSETS
Property, Plant & Equipment $2.761M $2.419M $2.177M
YoY Change 73.54% 50.25% 125.36%
Goodwill $9.200M
YoY Change
Intangibles $7.969M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.198M $1.315M $1.180M
YoY Change -31.78% -32.08% -34.37%
Total Long-Term Assets $25.40M $8.317M $8.243M
YoY Change 188.04% -10.55% -6.23%
TOTAL ASSETS
Total Short-Term Assets $223.9M $238.7M $243.0M
Total Long-Term Assets $25.40M $8.317M $8.243M
Total Assets $249.3M $247.0M $251.2M
YoY Change 49.9% 48.36% 46.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.663M $1.234M $2.162M
YoY Change -16.22% 22.91% 27.93%
Accrued Expenses $8.564M $5.957M $4.350M
YoY Change 73.78% 20.49% 44.47%
Deferred Revenue $7.419M $6.841M $5.779M
YoY Change 53.19% 72.53% 74.01%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.08M $15.43M $13.66M
YoY Change 46.06% 38.07% 47.77%
LONG-TERM LIABILITIES
Long-Term Debt $15.00M $15.00M $15.00M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $542.0K $15.45M $15.76M
YoY Change 179.38% 7861.86% 8023.71%
Total Long-Term Liabilities $15.54M $15.00M $15.00M
YoY Change 2.29% -1.28% -1.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.08M $15.43M $13.66M
Total Long-Term Liabilities $15.54M $15.00M $15.00M
Total Liabilities $52.78M $45.88M $44.42M
YoY Change 21.26% 15.23% 15.57%
SHAREHOLDERS EQUITY
Retained Earnings -$124.4M -$118.2M -$110.1M
YoY Change 27.98% 28.48% 30.14%
Common Stock $32.00K $32.00K $31.00K
YoY Change 14.29% 14.29% 14.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $196.5M $201.1M $206.8M
YoY Change
Total Liabilities & Shareholders Equity $249.3M $247.0M $251.2M
YoY Change 49.9% 48.36% 46.27%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.259M -$8.099M -$9.415M
YoY Change 20.71% 9.09% 54.47%
Depreciation, Depletion And Amortization $459.0K $311.0K $267.0K
YoY Change 75.86% 32.34% 94.89%
Cash From Operating Activities -$4.938M -$10.41M -$466.0K
YoY Change 68.88% 42.45% -95.16%
INVESTING ACTIVITIES
Capital Expenditures -$744.0K -$72.00K $617.0K
YoY Change 1182.76% -88.29% 6755.56%
Acquisitions
YoY Change
Other Investing Activities -$13.76M
YoY Change
Cash From Investing Activities -$14.51M -$72.00K -$617.0K
YoY Change 24910.34% -88.29% 6755.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 171.0K 467.0K 130.0K
YoY Change -64.6% 66.79% -122.97%
NET CHANGE
Cash From Operating Activities -4.938M -10.41M -466.0K
Cash From Investing Activities -14.51M -72.00K -617.0K
Cash From Financing Activities 171.0K 467.0K 130.0K
Net Change In Cash -19.27M -10.02M -953.0K
YoY Change 671.23% 31.03% -90.66%
FREE CASH FLOW
Cash From Operating Activities -$4.938M -$10.41M -$466.0K
Capital Expenditures -$744.0K -$72.00K $617.0K
Free Cash Flow -$4.194M -$10.34M -$1.083M
YoY Change 46.34% 54.46% -88.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31590177
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212994000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
224073000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1750000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31413431
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27335637
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31312559
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27313125
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31077004
dei Entity Central Index Key
EntityCentralIndexKey
0001555279
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31531115
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39815
dei Entity Registrant Name
EntityRegistrantName
908 DEVICES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4524096
dei Entity Address Address Line1
EntityAddressAddressLine1
645 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
254-1500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MASS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1750000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11098000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16375000
CY2022Q2 us-gaap Inventory Net
InventoryNet
11178000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7918000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3408000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4527000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
238678000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
252893000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4583000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5182000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2419000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1603000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1315000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1228000
CY2022Q2 us-gaap Assets
Assets
246995000
CY2021Q4 us-gaap Assets
Assets
260906000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1234000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1371000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5957000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6961000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6841000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5160000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1402000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1344000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15434000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14836000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15000000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3797000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4508000
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11649000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11958000
CY2022Q2 us-gaap Liabilities
Liabilities
45880000
CY2021Q4 us-gaap Liabilities
Liabilities
46302000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31531115
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31077004
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
32000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
31000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319234000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
315210000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118151000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100637000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
201115000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
214604000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
246995000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
260906000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11106000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8277000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19412000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13820000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
4472000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
3898000
us-gaap Cost Of Revenue
CostOfRevenue
8649000
us-gaap Cost Of Revenue
CostOfRevenue
6533000
CY2022Q2 us-gaap Gross Profit
GrossProfit
6634000
CY2021Q2 us-gaap Gross Profit
GrossProfit
4379000
us-gaap Gross Profit
GrossProfit
10763000
us-gaap Gross Profit
GrossProfit
7287000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4293000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3055000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8198000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6020000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10710000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8779000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20455000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14532000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
15003000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
11834000
us-gaap Operating Expenses
OperatingExpenses
28653000
us-gaap Operating Expenses
OperatingExpenses
20552000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8369000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7455000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17890000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13265000
CY2022Q2 us-gaap Interest Expense
InterestExpense
15000
CY2021Q2 us-gaap Interest Expense
InterestExpense
39000
us-gaap Interest Expense
InterestExpense
35000
us-gaap Interest Expense
InterestExpense
415000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
285000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
70000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
411000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
161000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
270000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
31000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
376000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-254000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8099000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7424000
us-gaap Net Income Loss
NetIncomeLoss
-17514000
us-gaap Net Income Loss
NetIncomeLoss
-13519000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31413431
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27335637
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31312559
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27313125
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
214604000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
324000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1289000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9415000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
206802000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
276000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1894000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
242000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8099000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
201115000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
139041000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
339000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6095000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
133312000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
298000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
481000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-7424000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
126667000
us-gaap Profit Loss
ProfitLoss
-17514000
us-gaap Profit Loss
ProfitLoss
-13519000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
578000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
375000
us-gaap Share Based Compensation
ShareBasedCompensation
3183000
us-gaap Share Based Compensation
ShareBasedCompensation
820000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-171000
us-gaap Inventory Write Down
InventoryWriteDown
39000
us-gaap Inventory Write Down
InventoryWriteDown
48000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1725000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5277000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
224000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3857000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3943000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1119000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2188000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-18000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1177000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1043000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
482000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1372000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
519000
mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-599000
mass Increase Decrease In Right Of Use Operating Assets
IncreaseDecreaseInRightOfUseOperatingAssets
-551000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-653000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-578000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10876000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16938000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
689000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
625000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-689000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-625000
mass Payments For Withholding Taxes On Vested Awards
PaymentsForWithholdingTaxesOnVestedAwards
133000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
842000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
325000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
112000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
576000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
30000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
15000000
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
30000000
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
15000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
39000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
597000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-290000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10968000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17853000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
224133000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159227000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213165000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141374000
mass Property And Equipment Included In Account Payable
PropertyAndEquipmentIncludedInAccountPayable
147000
mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
558000
mass Transfers Of Inventory To Property And Equipment
TransfersOfInventoryToPropertyAndEquipment
510000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212994000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141314000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
60000
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
60000
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
111000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213165000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141374000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-02-10
CY2021Q4 mass Proceeds From Issuance Secondary Public Offering
ProceedsFromIssuanceSecondaryPublicOffering
94400000
us-gaap Net Income Loss
NetIncomeLoss
-17500000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22200000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:28.8pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition and accounts receivable, the valuation of inventory and the valuation of stock-based awards. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require further updates to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these condensed consolidated financial statements. These estimates may change, as new events occur and additional information is obtained. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results may differ from those estimates or assumptions.</p>
mass Concentrations Of Credit Risk And Of Significant Customers
ConcentrationsOfCreditRiskAndOfSignificantCustomers
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk and of Significant Customers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:28.8pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents with two financial institutions that management believes to be of high credit quality. The Company has not experienced any other-than-temporary losses with respect to its cash and cash equivalents and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:28.8pt;margin:0pt 0pt 12pt 0pt;">Significant customers are those that accounted for 10% or more of the Company’s total revenue or accounts receivable. For the three months ended June 30, 2022 and 2021, one customer represented 17% and 14% of total revenue, respectively. For the six months ended June 30, 2022 and 2021, one customer represented 19% and 16% of total revenue, respectively. As of June 30, 2022, one customer accounted for 13% of gross accounts receivable. As of December 31, 2021, two customers accounted for 63% and 11%, respectively, of gross accounts receivable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:28.8pt;margin:0pt 0pt 12pt 0pt;">The credit and economic conditions within countries in Europe, Middle East and Africa that the Company does business with have been weak in recent years. These conditions have continued to deteriorate as a result of COVID-19 and may continue to increase the average length of time that it takes to collect on the accounts receivables outstanding in these countries. As of June 30, 2022, the gross accounts receivable balance from these countries amounted to $3.2 million, of which $1.7 million is more than 90 days past due and for which the Company has provided for an allowance for doubtful accounts of $1.7 million.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:28.8pt;margin:0pt 0pt 12pt 0pt;">Certain of the components included in the Company’s products are obtained from a sole source, a single source or a limited group of suppliers. Although the Company seeks to reduce dependence on those limited sources of suppliers and manufacturers, the partial or complete loss of certain of these sources, or the requirement to establish a new supplier for the components, could have a material adverse effect on the Company’s operating results, financial condition and cash flows and damage its customer relationships.</p>
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1700000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6753000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3965000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4204000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2001000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4933000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3745000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15890000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9711000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11106000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8277000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19412000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13820000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11106000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8277000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19412000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13820000
CY2022Q2 mass Number Of Vote For Each Share Of Common Stock
NumberOfVoteForEachShareOfCommonStock
1
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
7621000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6242000
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2666000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
551000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
891000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1125000
CY2022Q2 us-gaap Inventory Net
InventoryNet
11178000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7918000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2793000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3271000
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1283000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1593000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
905000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
710000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
976000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1387000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5957000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6961000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1593000
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1265000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1166000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
500000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1476000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
775000
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1283000
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
990000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3112101
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3326652
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1894000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
481000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3183000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
820000
CY2022Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
13300
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P88M
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
4000000.0
CY2022Q2 mass Number Of Parties With Royalty Arrangements
NumberOfPartiesWithRoyaltyArrangements
2
CY2022Q2 mass Royalty Liabilities Future Minimum Royalty Payments Annual
RoyaltyLiabilitiesFutureMinimumRoyaltyPaymentsAnnual
100000
CY2021Q4 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021Q4 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
CY2021Q4 mass Defined Contribution Plan Employer Matching Contribution Annual Maximum Per Employee
DefinedContributionPlanEmployerMatchingContributionAnnualMaximumPerEmployee
3500
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000

Files In Submission

Name View Source Status
0001558370-22-012746-index-headers.html Edgar Link pending
0001558370-22-012746-index.html Edgar Link pending
0001558370-22-012746.txt Edgar Link pending
0001558370-22-012746-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mass-20220630.xsd Edgar Link pending
mass-20220630x10q.htm Edgar Link pending
mass-20220630xex31d1.htm Edgar Link pending
mass-20220630xex31d2.htm Edgar Link pending
mass-20220630xex32d1.htm Edgar Link pending
mass-20220630xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
mass-20220630_lab.xml Edgar Link unprocessable
mass-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mass-20220630x10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mass-20220630_cal.xml Edgar Link unprocessable
mass-20220630_def.xml Edgar Link unprocessable